Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04457596 |
|---|---|
| Brief Title: | T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial |
| First Submitted : | June 30, 2020 |
| First Submitted that Met QC Criteria : | June 30, 2020 |
| First Posted : | July 7, 2020 |
| Last Update Submitted that Met QC Criteria : | April 8, 2024 |
| Last Update Posted : | April 9, 2024 |